APC Panel Calls For External Data To Resolve Outpatient Payment Issues
This article was originally published in The Gray Sheet
Executive Summary
CMS' Ambulatory Payment Classification Advisory Panel recommended the agency incorporate external data to settle discrepancies with device-related payment groupings in the outpatient prospective payment system
You may also be interested in...
Stakeholders To Address CMS Advisory Panel On Outpatient Payment Issues
Prosthetic urologists will be among device stakeholders seeking improved Medicare outpatient payment in 2005 when CMS' Ambulatory Payment Classification Advisory Panel convenes in Baltimore Sept. 1-3
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.